調查批次:CHT2015-04 | 檢體寄出日期:2015-04-27 | 報告回收截止日期:2015-05-04 | 回收份數:21 |
TSH 檢驗院際品管調查結果: | ||
2.歷次品管檢體 TSH 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
1 |
3 |
21.8 |
6.2 |
39.7 |
5.0 |
1.1 |
165 |
6.5 |
1.6 |
32.7 |
4.1 |
0.5 |
137 |
RH07b | RH07 | 7 |
1 |
3 |
19.8 |
4.2 |
26.9 |
3.4 |
-0.4 |
112 |
6.3 |
1.4 |
28.6 |
3.6 |
0.0 |
120 |
RH14 | RH14 | 4 |
1 |
3 |
18.3 |
2.7 |
17.3 |
2.2 |
-1.4 |
72 |
6.3 |
1.4 |
28.6 |
3.6 |
0.0 |
120 |
RH15 | RH15 | 7 |
1 |
3 |
20.0 |
4.4 |
28.2 |
3.5 |
-0.2 |
117 |
6.5 |
1.6 |
32.7 |
4.1 |
0.5 |
137 |
CL009 | CL009 | 7 |
1 |
3 |
20.9 |
5.3 |
34.0 |
4.2 |
0.4 |
141 |
6.4 |
1.5 |
30.6 |
3.8 |
0.3 |
128 |
CL010 | CL010 | 3 |
1 |
3 |
22.0 |
6.4 |
41.0 |
5.1 |
1.2 |
171 |
6.3 |
1.4 |
28.6 |
3.6 |
0.0 |
120 |
CL012 | CL012 | 7 |
1 |
3 |
20.2 |
4.6 |
29.5 |
3.7 |
-0.1 |
123 |
6.3 |
1.4 |
28.6 |
3.6 |
0.0 |
120 |
CL013 | CL013 | 3 |
1 |
5 |
21.2 |
5.6 |
35.9 |
4.5 |
0.6 |
149 |
5.7 |
0.8 |
16.3 |
2.1 |
-1.5 |
68 |
CL014a | CL014 | 7 |
1 |
3 |
18.6 |
3.0 |
19.2 |
2.4 |
-1.2 |
80 |
5.6 |
0.7 |
14.3 |
1.8 |
-1.8 |
60 |
CL015 | CL015 | 7 |
1 |
3 |
20.5 |
4.9 |
31.4 |
3.9 |
0.1 |
131 |
6.8 |
1.9 |
38.8 |
4.9 |
1.3 |
162 |
Median of RIA Group |
20.4 |
6.3 |
||||||||||||||
Range of RIA Group |
18.3 - 22.0 |
5.6 - 6.8 |
||||||||||||||
Robust mean of RIA Group |
20.3 ( n = 10 ) |
6.3 ( n = 10 ) |
||||||||||||||
Robust SD of RIA Group |
1.39 |
0.39 |
||||||||||||||
CV of RIA Group |
6.8% |
6.2% |
||||||||||||||
Median of European RIA Labs |
15.8 ( n = 106 ) |
5.2 ( n = 104 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
14.8 - 20.7 |
4.6 - 6.6 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 2 |
3 |
9 |
15.4 |
-0.2 |
-1.3 |
-0.2 |
0.4 |
-5 |
4.9 |
0.0 |
0.0 |
0.0 |
0.6 |
0 |
RH02c | RH02 | 7 |
3 |
1 |
12.1 |
-3.5 |
-22.4 |
-2.8 |
-2.5 |
-93 |
3.8 |
-1.1 |
-22.4 |
-2.8 |
-1.6 |
-94 |
RH06 | RH06 | 2 |
3 |
9 |
15.6 |
0.0 |
0.0 |
0.0 |
0.6 |
0 |
5.0 |
0.1 |
2.0 |
0.3 |
0.8 |
9 |
RH07a | RH07 | 2 |
3 |
2 |
14.8 |
-0.8 |
-5.1 |
-0.6 |
-0.1 |
-21 |
4.4 |
-0.5 |
-10.2 |
-1.3 |
-0.4 |
-43 |
RH12 | RH12 | 2 |
3 |
2 |
15.8 |
0.2 |
1.3 |
0.2 |
0.8 |
5 |
4.9 |
0.0 |
0.0 |
0.0 |
0.6 |
0 |
RH19 | RH19 | 5 |
3 |
2 |
14.8 |
-0.8 |
-5.1 |
-0.6 |
-0.1 |
-21 |
4.8 |
-0.1 |
-2.0 |
-0.3 |
0.4 |
-9 |
RH20 | RH20 | 2 |
3 |
7 |
14.3 |
-1.3 |
-8.3 |
-1.0 |
-0.5 |
-35 |
4.3 |
-0.6 |
-12.2 |
-1.5 |
-0.6 |
-51 |
CL005 | CL005 | 3 |
3 |
9 |
14.6 |
-1.0 |
-6.4 |
-0.8 |
-0.3 |
-27 |
4.8 |
-0.1 |
-2.0 |
-0.3 |
0.4 |
-9 |
CL006a | CL006 | 3 |
3 |
7 |
13.5 |
-2.1 |
-13.5 |
-1.7 |
-1.3 |
-56 |
4.1 |
-0.8 |
-16.3 |
-2.1 |
-1.0 |
-68 |
CL008 | CL008 | 4 |
3 |
2 |
15.3 |
-0.3 |
-1.9 |
-0.2 |
0.4 |
-8 |
4.5 |
-0.4 |
-8.2 |
-1.0 |
-0.2 |
-34 |
CL011 | CL011 | 0 |
3 |
13 |
16.9 |
1.3 |
8.3 |
1.0 |
1.8 |
35 |
5.4 |
0.5 |
10.2 |
1.3 |
1.6 |
43 |
Median of CLIA Group |
14.8 |
4.8 |
||||||||||||||
Range of CLIA Group |
12.1 - 16.9 |
3.8 - 5.4 |
||||||||||||||
Robust mean of CLIA Group |
14.9 ( n = 11 ) |
4.6 ( n = 11 ) |
||||||||||||||
Robust SD of CLIA Group |
1.12 |
0.49 |
||||||||||||||
CV of CLIA Group |
7.5% |
10.7% |
||||||||||||||
Median of European CLIA Labs |
15.6 ( n = 1203 ) |
4.9 ( n = 1221 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
13.0 - 16.7 |
4.2 - 5.2 |
||||||||||||||
Median of All Labs |
16.9 |
5.4 |
||||||||||||||
Range of All Labs |
12.1 - 22.0 |
3.8 - 6.8 |
||||||||||||||
Robust mean of All Labs |
17.5 ( n = 21 ) |
5.4 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
3.46 |
1.05 |
||||||||||||||
CV of All Labs |
19.8% |
19.4%
|
||||||||||||||
Median of All European Labs ( Xa ) |
15.6 |
4.9 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
13.1 - 16.9 |
4.2 - 5.3 |
||||||||||||||
Mean of All European Labs |
15.4 ( n = 1430 ) |
4.9 ( n = 1429 ) |
||||||||||||||
SD of All European Labs |
2.06 |
0.59 |
||||||||||||||
CV of All European Labs |
13.4% |
12.2% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
1.248 |
0.39 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Sandwich-type ) |
1 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015, |
Chemiluminescent Immunoassay ( Sandwich-type ) |
3 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Immunotech |
5 |
CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2015-05-06